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In Vitro Analysis of Multistage
Carcinogenesis
by P. Nettesheim,* D. J. Fitzgerald,* H. Kitamura,*
C. L. Walker,* T. M. Gilmer,* J. C. Barrett,* and T. E. Gray*
Several key events in the multistep process of neoplastic transformation of rat tracheal epithelium
(RTE) are described. Whether tracheal epithelium is exposed in vivo to carcinogenic agents or whether
primary tracheal epithelial cells are exposed in vitro to carcinogens, initiated stem cellst can be detected
soon afterthe exposure bytheir ability to grow under selective conditions in culture. These initiated stem
cells differ fundamentally from normal stem cells in their response to factors normally constraining
proliferation and self-renewal. Thus, disruption ofinhibitory control mechanisms ofstem cell replication
appears to be the first event in RTE cell transformation. While the probability of self-renewal (PSR) is
clearly increased in initiated stem cells, most ofthe descendants derived from such stem cellsdifferentiate
and become terminal and do not express transformed characteristics.
Progression from the first to the second stage of RTE cell transformation, the stage of the immortal
growthvariant(IGV), ischaracterizedby lossofresponsivenesstothegrowth-restrainingeffectsofretinoic
acid. In the third stage of neoplastic transformation, the stage during which neoplastic growth variants
(NGV) appear, a growth factor receptor gene is inappropriately expressed in some of the transformants.
Thus, it appears that loss of growth-restraining mechanisms may be an early event, and activation of a
growth stimulatory mechanism a late event, in neoplastic transformation of RTE cells.
Introduction
The combined epidemiological, clinical, and experi-
mental evidence suggests that the development of can-
cer occurs in discrete stages. According to current
models of carcinogenesis such as the one presented in
Figure 1 (1), carcinogen exposure does not instantly
transform the affected target cells to cancer cells,
rather, it causes heritable changes in asmallproportion
of stem cells, converting them to a preneoplastic state
(internediate cells in Fig. 1). In the second stage of
carcinogenesis, clonal expansion of the preneoplastic
stem cell variants occurs. This can be brought about by
exogenous promoting agents (such as phenobarbital,
dioxins, or phorbol esters), by endogenous promoters
(e.g., prolactin in mamma r carcinogenesis), or it may
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tTerminology used: stem cell: a cell with self-replicating ability;
we consider clonogenic cells to be stem cells. Initiated stem cell: the
stem cell that has beenheritably altered by exposure to a carcinogen
and as aresult ofthat exposure produces progenywith agreaterthan
normal probability ofbecoming neoplastic. We consider the founder
cell of the enhanced growth variant colony (EGV colony) to be an
initiated stem cell. Preneoplastic cells: any cell whether appearing
early or late during the multistage process of neoplastic transfor-
mation that has a greater than normal probability of giving rise to
neoplastic offspring.
First Event Second Event
FIGURE 1. Two-stage model of carcinogenesis. S = normal stem
cells; I = intermediate stem cells (these are usually called "initi-
ated" cells; we consider them to be preneoplastic, as their prob-
ability to become neoplastic is increased); N = neoplastic stem
cells; T = terminal cells. p, = Rate at which first event occurs;
p = rate at which second event occurs; a2 = rate ofdivision ofI;
12 = rate of commitment to terminal state of I. Modified from
Moolgavkar and Knudson (1).
occur without an identified stimulus. As a result ofthe
proliferative expansionofthepreneoplasticclone, anew
cell variant with neoplastic characteristics arises. Ad-
ditional steps may be required for various neoplasticNETTESHEIM ETAL.
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FIGURE 2. Growth ofnormnal and transformned primary rat tracheal
epithelial cells. (o) Normnal cells; (a) cells exposed to N-methyl-
N'-nitro-N-nitrosoguanidine, MNNG.
phenotypes to appear (e.g., invasiveness, metastatic
ability, hormone independence). This model of carein-
ogenesis is, as one might imagine, not uncontested.
However, in principle, this model is supported by a
great wealth of experimental data and by studies on
heritable neoplastic diseases in humans such as familial
retinoblastoma (2). For the purposes of this presenta-
tion, itmay serve toprovidethe overallperspective and
the hypothetical framework for the discussion of our
own investigations.
Ourinterestisprimarilyfocused onthe compartment
of intermediate preneoplastic transfonnants (Fig. 1).
What experimental evidence do we have that preneo-
plastic stem cells exist? Can they be isolated? How do
they differ in their behavior from normal stem cells?
What is the molecular basis of their phenotype? What
is involved in the conversion ofthe preneoplastic to the
neoplastic cell variant, a process we call progression,
and what factors can accelerate or inhibit that progres-
sion? Preneoplastic cellsthat have notyetacquired ma-
lignant characteristics presumably are present only in
small numbers. Thus, it may be possible to prevent the
progression of preneoplastic cells to malignancy or to
eliminate them fromthe host altogether through chem-
opreventive measures. The studies to be discussed are
concerned with the following topics: the detection, iso-
lation, and quantification of early, preneoplastic stem
cells in rat tracheal epithelium; manifestations ofaber-
rant growth control in these early transfornants and
their abnormal self-renewal capacity; manifestations of
progression, namely, the loss ofresponsiveness to neg-
ative growth regulators; and altered gene expressionin
late stages ofneoplastic transformation. The examples
used in this review to illustrate the manifestations of
altered growth control of RTE cell transformants are
takenfromseveralinvitrotransformationstudies;how-
ever, transformants isolated from tracheal epithelium
exposed in vivo to various types of carcinogens show
the same growth alterations and the same sequence of
phenotypic changes during progression from the pre-
neoplastic to the neoplastic stages oftransformation.
FIGURE 3. Nornal and transformed rat tracheal epithelial cell colonies. Left, day-7 colonies. Right, transforIned colonies after 5 weeks of
selection.
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FIGURE 4. In vitro assay for detection ofpreneoplastic stem cell variants formed in vivo, following exposure oftracheas to carcinogens. Rats
are exposed to a tracheal carcinogen. At different times after carcinogen exposure tracheas are removed, the epithelium is dissociated and
plated on irradiated 3T3 feeder cells. Four days after plating, feeder cells are removed to select for transformed stem cells, which form
large colonies within 3to 5weeks after startofselection (enhanced growth variant colonies = EGV-colonies). The EGV-colonies areisolated,
replated, and subcultured repeatedly. Different passages (P5-P15) are inoculated into compatible hosts to examine the neoplastic potential.
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FIGURE 5. Schematicrepresentation ofmultistagecarcinogenesis of
rat tracheal epithelial cells. The same phenotypic changes are ob-
served in cells initiated in vivo or in vitro. RTE = normal rat
tracheal epithelial cells; EGV = enhanced growth variant;
IGV = immortal growth variant; NGV = neoplastic growth var-
iant; AiGV = anchorage independent growth variant; the AiGV is
not an obligatory preneoplastic phenotype.
Detection, Isolation and
Quantification of Early
Preneoplastic Transformants
Carcinogen exposure causes cellular and molecular
changes that, months and years later, result in the de-
velopment of tumors. To investigate the clonal expan-
sion and progression ofthe putative initiated stem cells
during this long latency period, one must be able to
isolate the stem cells and study their descendants over
many cell generations. More than 10 years ago, studies
inourlaboratory (3,4)led tothediscoverythattracheas
ofratsexposedtocarcinogenscontainasmallproportion
ofcellsexhibitingafundamentalderangementingrowth
control. This becomes evident when the cells from such
tracheas are isolated and cultured. Epithelial cells ob-
FIGURE 6. Effect of carcinogen dose and time after the end of ex-
posure on the rate of appearance of advanced preneoplastic cell
variants. Tracheas were exposed in vivo to various amounts of
7,12-dimethylbenz[a]anthracene for a period of 2 weeks. At dif-
ferrent times after the end of exposure 10 to 20 tracheas were
removed and the numberoftracheas containingtransformed stem
cellsgivingrise to anchorage independentgrowthvariants aswell
as the relative frequency of such transformed stem cells (i.e.,
AiGV/EGV %) was determined (3,4).
tained from tracheas of normal rats undergo approxi-
mately 10 population doublings inprimary culture (Fig.
2); thereafter, they senesce and become terminal. In
contrast, cells that have been exposed to carcinogens
either in vivo or in vitro proliferate indefinitely. Ifthe
cells are seeded at clonal densities (Fig. 3), one can
observe many small colonies around 8 to 10 days after
plating; however, subsequently, most ofthese senesce
and only a few (0.5-2.0%) continue to expand and can
be scored as "enhanced growth variant (EGV) clones"
several weeks later (5). This is regarded as the first
stage of RTE cell transformation (Fig. 4). These en-
hanced growth variant colonies canbe isolated and sub-
cultured. Approximately one-half of these clones
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FIGURE 7. Model of stem cell differentiation. From Buick and Pol-
lack (8).
become permanent cell lines, i.e., they undergo im-
mortalization (IGV = immortal growth variants) and
between 30 and 50% ofthe immortalized clones become
neoplastic (NGV = neoplastic growth variants) after 5
to20passages. Theanchorage-independentgrowthvar-
iant (AiGV), which is frequently observed when the
tracheal epithelium is initiated in vivo, is not an oblig-
atorypreneoplastic phenotype. Thus wehave identified
three different stages of neoplastic transformation in
cells isolated from rat tracheas exposed in vivo to car-
cinogens (EGV, IGV, NGV), and we can say with con-
fidence that the early EG-variant clones are preneo-
plastic because they have an increased probability of
becoming neoplastic (Fig. 5).
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PreneoplasticstemcellswithEGVcharacteristics can
be detected inthetracheal epitheliumwithinafewdays
after in vivo carcinogen exposure. Obviously it is of
great interest to learn about the fate of this cell com-
partment during the tumor latency period. Following a
single carcinogen exposure, which causes an approxi-
mate 20% tumor incidence at about 24 months, the pre-
neoplastic stem cell population expands (Fig. 6). As a
function of time, the number of tracheas containing
transformants increases and the number oftransform-
antspertracheaalsoincreases. Thegrowthofthetrans-
formned stem cell pool is carcinogen-dose dependent. It
is important to note that the expansion ofpreneoplastic
cells in the tracheal epithelium occurs in the absence of
any exogenous stimulus and many months before tu-
mors arise.
In summary, we showed that early preneoplastic cell
variants can be isolated from carcinogen-exposed tra-
cheal epithelium of rats and can be quantitated in cell
culture; the number of these early transformants in-
creasesasafunctionofcarcinogendoseandasafunction
of time after exposure; and their clonal descendants
undergo secondary changes, most importantly, immor-
talization and neoplastic transformation. Other labora-
tories have observed similar findings: cells with char-
acteristics of EG-variants have been isolated from a
number of organs in rats (6) and from initiated mouse
skin (7).
Analysis of the Aberrant Self-
Renewal of EG-Variant Clones
According to the two-stage model of carcinogenesis
presented by Moolgavkar and Knudson (1), neoplastic
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FIGURE 8. Effect ofcelldensityongrowth and stemcellcompartment size. (A)Culturesofnormaland (B)oftransformedrattrachealepithelial
cells. (0)Cell number perculture; (o)percent clonogenic cells. (CFE = colonyformingefficiency was assayed on 3T3feedercells tomaximize
expression ofcolony forming ability.)
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FIGURE 9. Frequency of clonogenic units (stem cells) in primary
EGV clones 5 weeks after MNNG exposure. More than 40 indi-
vidual EGV colonies were tested under optimized growth condi-
tions on feeder cells (0)CFEf, and under selective growth con-
ditions on plastic (e)CFEpl. Each circle represents one EGV
colony containing -10i cells. From Fitzgerald et al. (10).
transformation is a stemcelldisorder. Ifthishypothesis
is correct, we should be able to detect abnormal stem
cell growth kinetics during early preneoplastic stages
of neoplastic transformation. Before we describe the
proliferation kinetics of EG-variant clones, it may be
useful tobrieflyreview asimplemodel ofcellreplication
in differentiating tissues (Fig. 7). This model (8) pos-
tulates three main cell compartments: a compartment
of cells endowed with the capacity for self-renewal (so-
called stem cells); a compartment of committed, repli-
cating cells responsible for expansion ofthe clone; and
a compartment of terminally differentiated cells, car-
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FIGURE 10. Relative growth rate ofstem cell compartments inEGV
colonies. The growth of EGV colonies (average number of cells/
colony) was measured in primary culture between 5 and 12 weeks
after MNNG exposure. Also measured was the size of the clono-
genic cell compartments under permissive (feeder' = in presence
of 3T3 feeder cells) and under selective (feeder- = in absence of
3T3 feeder cells) conditions. CFU = colony-forming units. The
CFU which replicate on plastic in the absence offeeder cells are
thought to be responsible for immortalization of the EGV clones
(EGV-. IGV). From Fitzgerald et al. (10).
rying out the main differentiated functions of the re-
spective tissue.
In normal steady-state epithelia, most of the stem
cells are believed to remain in Go and thus are noncy-
cling. When they enter cell cycle, their probability for
self-renewal (PSR) is 50%. Duringnonsteady-state con-
ditions such as regenerative growth or neoplastic dis-
ease, the PSR increases and the stem cell compartment
increasesin size. In cellculture, onedeterminesthe size
of the stem cell compartment by means of clonogenic
assays that measure the proportion of clone-forming
cells in a cell population. Typically, during the growth
ofnormal primary rat tracheal cells (Fig. 8A), the num-
ber of clonogenic cells, or stem cells, in the population
amounts to only a few percent during the early loga-
rithmic growth phase, and as the clonal cell density
increases and the cultures approach plateau ofgrowth,
the stem cell compartment decreases rapidly in size.
Simultaneously the cultures produce terminally differ-
entiated cells. Ultimately cellreplication ceases and the
cultures senesce.
This dynamic relationship between clonogenic cells,
committed cells, and terminally differentiated cells is
fundamentally altered in transformed cell populations.
To emphasize this change we have chosen to illustrate
the growth dynamics of a preneoplastic, immortalized
growth variant (IGV) (Fig. 8B); the growth rate is sim-
ilartothatofnormalcellsduringthelogarithmicgrowth
phase. However, subsequently, two crucial differences
are noted: growth continues in spite of the high cell
density being reached, and the clonogenic cell com-
partment does not decrease in response to high cell
density (the same phenomenon is seen in early trans-
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FIGURE 11. Loss of retinoic acid (RA) sensitivity of early RTE cell transformants as a function of time. EGV colonies were isolated at
different times after MNNG exposure, dissociated and replated at clonal density, and treated with different concentrations of RA. The
effect of RA on the colony-forming ability of the replated cells was determined after 7 days. From Fitzgerald et al. (13).
Table 1. Quantitation of c-onc expression in EGV-T cell lines.a
N-myc, abl, erb-B,fes,
fms H-ras K-ras raf fos L-myc c-myc myb, ros, sis, kit
Normal rat tracheal epithelial (RTE) cells 1 1 1 1 1 1 1 No detectable
expression
EGV4T 5* 3* 2 2 G1 G1
EGV5T 5* 3* 2 2 G1 G1 61
EGV6T 19* 3* G1 2 G1 G1 S1
EGV1OT 61 61 61 61 ND G1 ND
ND = Not determined.
aDot blot analysis ofcytoplasmic RNA ofindependently transformed, tumor-derived RTE cell lines and normal RTE cells grown in primary
culture.
*Significant (p G 0.05).
formants, EGV clones). It is clear that the regulation
ofthe size ofthe stem cell compartment in these trans-
formants is altered. It is important to note, however,
that even in the immortal growth variant, only 10% of
the cells are clonogenic, i.e., a substantial proportion of
cells in these IG-variant cultures differentiate and be-
come terninal (9,10). Thus, the transformed phenotype
is transmitted to only a fraction of the descendants of
the transformed stem cell. In the early transformants,
namely the EG-variants, the stem cell compartment is
even smaller (Fig. 9). Most of the transformed clones
have S 1% cells with clonogenic potential, and at most
10 to 20%. Autoradiographic studies have shown that
the growth fraction, i.e., all cells able to proliferate, is
not more than -30%, and a large proportion of cells
shows ultrastructural evidence of terminal differentia-
tion (9). However, as the EG-variant clones progress
and acquire unlimited growth capacity (i.e., become im-
mortal) (Fig. 10), the fraction of EGV-stem cells in-
creases disproportionately within each clone (10). The
significance of this steady increase in the size of the
preneoplastic stemcellcompartment seemsobvious: the
larger the pool of proliferating stem cells, the greater
the chance for a new cell variant to arise. This brings
us to the third topic of ourdiscussion, namely, the man-
ifestations ofprogression.
Manifestations of Progression in
Early Preneoplastic Clones: Loss of
Responsiveness to Retinoic Acid
One can view neoplastic growth behavior as a con-
sequence of abnormal growth stimulation (e.g., auto-
crine growth stimulation) or as a result of diminished
growth restraints. There is in fact evidence for both
mechanisms operatinginneoplastictransfornation. We
areespeciallyinterestedinexploringthepossiblebreak-
down ofnegativegrowth controlmechanisms as acausal
eventin earlystages oftransformation. Onekeygrowth
anddifferentiationregulatorofnormalRTE cellsin vivo
is vitamin A and related retinoids. Withdrawal of vi-
tamin A from the diet results in increased cell prolif-
eration and squamous metaplasia of the tracheal epi-
thelium (11). Thus, retinoic acid (RA) can be regarded
as a physiological, negative growth regulator. It has
also been shown to inhibit the development of skin,
mammary, and bladder tumors in mice and rats (12).
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FIGURE 12. Northern analysis of RNA from several tumor-derived
RTE celllinesusing av-fmsprobe. SamplesofpolyA' cytoplasmic
RNA from rat embryo fibroblasts (REF) or EGV-T cell lines (4T,
5T, 6T, and lOT are independently transformed, tumor-derived
RTE cell lines) were separated by electrophoresis in formalde-
hyde/agarose gels, transferred to nitrocellulose, and hybridized to
3' v-fms probe. From Walker et al (14).
In our studies we found that RA inhibits growth of
normal RTE cells and inhibits the development ofRTE
cell transformants when the cultures are treated as
early as 1 day or as late as 20 days after carcinogen
exposure (13). What is perhaps more interesting is that
the sensitivity to RA of clonogenic cells isolated from
transformed colonies (EG-variant colonies) decreases
markedly with time (Fig. 11). The proliferation ofcells
isolated from 3-week-old transformants is readily inhib-
ited at low doses (the IC50, the dose needed to inhibit
......... ; S .................. : --:#.~~~~~~~~~~..........
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FIGURE 13. Northern analysis of RNA from EGV6-T and rat mac-
rophages using a vfis probe. Samples of poiy A' cytoplasmic
RNA from EGV6-T and normal rat alveolar macrophages (MAC)
were separated by electrophoresis in formaldehyde/agarose gels,
transferred to nitrocellulose, and hybridized to 3'-v-fins probe.
From Walker et al. (14).
colony formation by 50%, is 0.1 nM); however, clono-
genie cells from 9- and 12-week-old transformants be-
come increasingly resistant (IC50> 10 nM). We believe
that this loss ofRA sensitivity represents an important
step in the progression of the early EG-variant to be-
come an IG-variant, which escapes the growth regula-
tory function of RA. It is noteworthy that this change
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occurs concomitant with an increase in the size of the
transformed stem cell pool described earlier. The bio-
chemical and molecular mechanisms underlying these
changes need to be elucidated.
Insummary, wewouldliketoemphasizethefollowing
points: transformed stem cells produce a large propor-
tion of nontransformed, terminal offspring; in trans-
formed clones the stem cell pool size progressively and
selectivelyincreaseswithtime, whichisprobablylinked
to immortalization of the clone; and the transformed
stemcellprogressively losesresponsivenesstonegative
growth controlling factors such as high clonal cell den-
sity and retinoids.
Expression of Oncogenes during
Neoplastic Conversion
The RTE cell system is well suited to examine the
possible role ofoncogenes during various stages ofneo-
plastic transformation. We have begun to examine the
expression of oncogenes in neoplastic RTE cell trans-
formants. Five, independent, tumor-derived clones
were tested with a battery of oncogene probes (Table
1). Ofthe panel of 15 oncogenes whose level ofexpres-
sion was measured in the tumor-derived lines relative
to normal RTE cells, only two, H-ras andfms, showed
a significant elevation in the transformed cells. H-ras
elevation was threefold that observed in normal cells,
andfms was elevated 5- to 20-fold in three of the five
cell lines examined. Thefms-related gene observed in
these tumorigenic cell lines was expressed as an RNA
transcript of 9.5 kb in length (Fig. 12).
The humanfms gene encodes the receptor for mac-
rophage colony-stimulating factor, or CSF-1 (15). The
CSF-1 receptor/fms gene is expressed as a4.0 kb tran-
script in humans and mice. To determine the size ofthe
CSF-1 receptor/fms mRNAinrats, weisolatedpolyA'
RNAfromratalveolarmacrophages, whichexpressthe
CSF-1 receptor. We found thatthe CSF-1 receptor/fms
gene was expressed as a 3.8 kb transcript in these cells
(Fig. 13), comparable to the transcript size observed in
humans and mice. Thus, the gene expressed as a 9.5 kb
transcript in the epithelial cell lines is related to, but
distinct from, the CSF-1 receptor/fms gene. We spec-
ulate that this gene encodes a related growth factor
receptor, possibly for another hematopoietic growth
factor.
Because epithelial cells retain in their normal rep-
ertoire the capacity to synthesize and secrete various
hematopoietic growth factors such as granulocyte col-
ony-stimulating factor, ifthefms related gene encodes
the receptor for one of these growth factors, the pos-
sibility of autocrine transformation of cells expressing
thefms related gene exists. This could be an important
clue to the mechanisms underlying the neoplastic be-
havior of these cells. Conceivably, the growth factor
responsible for the unregulated growth of these cells
may be secreted by the neoplastic cells themselves.
Thus, at the early stages of RTE cell transformation,
loss ofresponsiveness to a negative growth regulator,
namely, retinoic acid, may be a key factor in the pro-
gression from enhanced growth variant to immortal
growthvariants; enhancedexpressionofagrowthfactor
receptorgenemaybeacrucialmechanismintheexpres-
sion oftheneoplastic phenotype. Obviously, muchwork
needs to be done before we know what role thefms-
related gene plays in the mechanism of transfomation
ofRTE cells. Studies to find the ligand forthis putative
growth factor receptor gene and determine at what
stage of neoplastic transformation the gene is first ex-
pressed are currently underway.
Our findings suggest that at least two distinct mech-
anisms may be involved in the multistage process of
neoplastic transformation ofrattrachealepithelialcells:
loss ofresponsiveness to physiological growth restrain-
ing factors in the early stages of transformation, and
activation ofgrowth stimulatory mechanisms resulting
from inappropriate expression of growth factor recep-
tors in late stages oftransformation.
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